Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income	$ (293,286)	$ 276,486
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	140,575	121,421
Lower of cost or market inventory valuation adjustment	560,464	(232,346)
Earnings of equity method investments, inclusive of distributions	(1,164)	(111)
Loss on early extinguishment of debt	25,915	0
(Gain) loss on sale of assets	(312)	(9)
Deferred income taxes	(150,726)	32,221
Equity-based compensation expense	6,330	9,374
Change in fair value - derivative instruments	(41,641)	20,909
(Increase) decrease in current assets:
Accounts receivable	301,535	(315,106)
Inventories	(50,468)	3,967
Income taxes receivable	(816)	(1,292)
Prepayments and other	6,741	6,543
Increase (decrease) in current liabilities:
Accounts payable	(328,222)	270,802
Income taxes payable	(11,056)	55,555
Accrued liabilities	16,892	43,480
Turnaround expenditures	(38,653)	(78,597)
Other, net	47,990	3,519
Net cash provided by (used for) operating activities	190,098	216,816
Cash flows from investing activities:
Additions to properties, plants and equipment	(64,807)	(53,017)
Purchase of business, net of cash acquired	0	(663,385)
Investment in equity company - HEP	(2,345)	0
Other, net	0	395
Net Cash Provided by (Used in) Investing Activities	(86,094)	(726,725)
Cash flows from financing activities:
Borrowings under credit agreement	112,000	104,000
Repayments under credit agreement	(67,000)	(85,000)
Proceeds from issuance of senior notes - HEP	500,000	0
Proceeds from issuance of common units - HEP	(522,500)	0
Purchase of treasury stock	(1,062)	(77,825)
Dividends	(57,248)	(56,849)
Contribution from Joint Venture Partner	7,304	0
Shares withheld for tax withholding obligations	(410)	(408)
Deferred financing costs	(8,478)	0
Proceeds from (Payments for) Other Financing Activities	(145)	(373)
Net cash used for financing activities	(71,457)	(150,128)
Effect of exchange rate on cash flow	(8,583)	1,424
Cash and cash equivalents:
Increase (decrease) for the period	23,964	(658,613)
Beginning of period	885,162	1,154,752
End of period	909,126	496,139
Cash paid during the period for:
Interest	(26,707)	(26,743)
Income taxes, net	(1,201)	(2,686)
HEP
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	23,978	23,830
Lower of cost or market inventory valuation adjustment	0	0
Cash flows from investing activities:
Additions to properties, plants and equipment	(18,942)	(10,718)
Cash flows from financing activities:
Payments to Noncontrolling Interests	$ (33,918)	$ (33,673)